Healthy Subject Clinical Trial
Official title:
Using Physical Activity to Facilitate Smoking Cessation Among African American Adults
Verified date | March 2024 |
Source | M.D. Anderson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized pilot clinical trial studies the use of physical activity in promoting the discontinuation of the habit of smoking (smoking cessation) in African Americans. Participating in physical activity during an actual smoking quit attempt may work better in helping African Americans stop smoking.
Status | Active, not recruiting |
Enrollment | 45 |
Est. completion date | January 31, 2027 |
Est. primary completion date | January 31, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 65 Years |
Eligibility | Inclusion Criteria: - Self-reported African-American race - Current daily smoker (has smoked >= 100 cigarettes in lifetime per self-report, smoked >= 5 cigarettes per day for the last 6 months per self-report) - Self-reports motivation to quit smoking within the next 2 weeks - Reports willingness to engage in a physical activity-based smoking cessation intervention - Has a home address and a functioning home and/or cell phone number - Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q) or by physicians clearance (letter from physician or nurse practitioner) if currently taking medication for blood pressure or diabetes - Willingness to wear the nicotine patches provided in the study as recommended - Have an expired carbon monoxide (CO) level > 8 parts per million (ppm) suggestive of current smoking - Blood pressure =< 140/90mm or by physicians clearance (letter from physician or nurse practitioner) if blood pressure reading > 140/90mm Hg Exclusion Criteria: - Contraindication for nicotine patch use - Regular use of tobacco products other than cigarettes in the last 30 days (including black & milds) - Current or planned future use of any nicotine replacement or pharmacological product for smoking cessation other than the study patches - Pregnancy or lactation - Another household member enrolled in the study - A schedule not accommodating to the study procedures, or unwillingness to adhere to the procedures |
Country | Name | City | State |
---|---|---|---|
United States | M D Anderson Cancer Center | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
M.D. Anderson Cancer Center | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment feasibility, defined as >= 75% of eligible/screened participants choose to enroll in the study | Up to 8 weeks | ||
Primary | Retention feasibility, defined as an overall retention rate of 80% and if each enrolled participant completes >= 66.7% of study visits (>= 6 of 9 study visits) | Up to 8 weeks | ||
Primary | Post intervention focus group analysis | Each focus group will use a semi-structured interview guide for consistency, which will consist of approximately 15 open-ended questions. If results do not suggest intervention feasibility, post-intervention focus groups will help to identify why feasibility was not achieved. Focus group transcripts will be imported into a qualitative data analysis software program, such as NVivo, to facilitate data retrieval and analysis and to organize data by themes based on phrases, patterns, relationships, and commonalties or disparities. | Up to 8 weeks | |
Secondary | Mechanisms underlying smoking cessation (e.g., stress, positive and negative affect, depression, smoking urges, self-efficacy, motivation, PA enjoyment, and heart rate variability) | Validated questionnaires via associated scoring manuals or by convention in the literature will be scored. Descriptive statistics, including mean and variance estimates with 95% confidence intervals, relevant to each of the identified mechanism variables, for each intervention group will be generated. Group*time effects with regard to stress, positive and negative affect, depression, smoking urges, self-efficacy, motivation, and heart rate variability will be examined using repeated measure analyses of variance as the primary analysis technique. | Up to 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02664883 -
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
|
||
Completed |
NCT05611281 -
GS3-007a Oral Solution in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03457480 -
Text Messages in Preventing Tobacco Use in Young Adults
|
N/A | |
Completed |
NCT05358756 -
A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT06037395 -
Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects
|
Phase 1 | |
Active, not recruiting |
NCT04032106 -
HPV Vaccine Intervention for Young Sexual Minority Men
|
N/A | |
Completed |
NCT04062955 -
Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants
|
N/A | |
Recruiting |
NCT03897270 -
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
|
N/A | |
Completed |
NCT01846520 -
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
|
N/A | |
Completed |
NCT02960100 -
mHealth Intervention in Increasing HPV Vaccinations in College Students
|
N/A | |
Completed |
NCT03698318 -
Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts
|
N/A | |
Completed |
NCT05497635 -
A Study of STSA-1002 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT03303846 -
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
|
N/A | |
Terminated |
NCT05559125 -
A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03584100 -
Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal
|
N/A | |
Recruiting |
NCT05117385 -
The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)
|
N/A | |
Active, not recruiting |
NCT05660720 -
Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03188848 -
Dose Escalating Study of BPI-3016 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01908920 -
Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects
|
N/A | |
Active, not recruiting |
NCT03491176 -
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
|
N/A |